-
PATH welcomes WHO prequalification of the first malaria vaccine
6 Sep 2022 -
PATH welcomes US$ 5 million grant to expand malaria vaccine access in Ghana, Kenya, and Malawi
19 Apr 2022 -
PATH welcomes commitment by Gavi board to finance wider rollout of the world’s first malaria vaccine, RTS,S
2 Dec 2021 -
PATH applauds WHO recommendation for broader use of first malaria vaccine
6 Oct 2021 -
PATH welcomes remarkable results from clinical trial combining RTS,S/AS01 malaria vaccine with Seasonal Malaria Chemoprevention
25 Aug 2021 -
PATH welcomes landmark financing agreement for GSK’s malaria vaccine
4 Aug 2021 -
GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine
27 Jan 2021 -
Milestone study identifies immune markers that may help predict success of vaccination with RTS,S/AS01 malaria vaccine
22 Jul 2020 -
PATH receives new five-year contract from USAID for malaria vaccine research and development
7 Jul 2020 -
PATH continues exciting partnership with the GHIT Fund to develop a next-generation malaria vaccine
3 Apr 2020 -
PATH and partners receive award for development of world’s first malaria vaccine
14 Nov 2019 -
Kenya joins Malawi and Ghana to roll out the world’s first malaria vaccine
13 Sep 2019